United States (US) Monoclonal Antibody Market (2025-2031) | Competitive Landscape, Growth, Outlook, Industry, Value, Forecast, Share, Size & Revenue, Companies, Segmentation, Trends, Analysis

Name: United States (US) Monoclonal Antibody Market (2025-2031) | Trends & Outlook
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Source (Murine, Chimeric, Humanized, Human), By Production (In Vivo, In Vitro), By Indication (Cancer, Autoimmune Diseases, Inflammatory Diseases, Infectious Diseases, Microbial Diseases, Others), By End use (Hospitals, Research Institutes, Others) And Competitive Landscape

Product Code: ETC9970804	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Shubham Padhi	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Monoclonal Antibody Market Outlook
Market Size of United States (US) Monoclonal Antibody Market, 2024
Forecast of United States (US) Monoclonal Antibody Market, 2031
Historical Data and Forecast of United States (US) Monoclonal Antibody Revenues & Volume for the Period 2021- 2031
United States (US) Monoclonal Antibody Market Trend Evolution
United States (US) Monoclonal Antibody Market Drivers and Challenges
United States (US) Monoclonal Antibody Price Trends
United States (US) Monoclonal Antibody Porter's Five Forces
United States (US) Monoclonal Antibody Industry Life Cycle
Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Source for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Murine for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Chimeric for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Humanized for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Human for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Production for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By In Vivo for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By In Vitro for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Indication for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Autoimmune Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Inflammatory Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Infectious Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Microbial Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By End use for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Hospitals for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Research Institutes for the Period 2021- 2031
Historical Data and Forecast of United States (US) Monoclonal Antibody Market Revenues & Volume By Others for the Period 2021- 2031
United States (US) Monoclonal Antibody Import Export Trade Statistics
Market Opportunity Assessment By Source
Market Opportunity Assessment By Production
Market Opportunity Assessment By Indication
Market Opportunity Assessment By End use
United States (US) Monoclonal Antibody Top Companies Market Share
United States (US) Monoclonal Antibody Competitive Benchmarking By Technical and Operational Parameters
United States (US) Monoclonal Antibody Company Profiles
United States (US) Monoclonal Antibody Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Monoclonal Antibody Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Monoclonal Antibody Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Monoclonal Antibody Market - Industry Life Cycle

3.4 United States (US) Monoclonal Antibody Market - Porter's Five Forces

3.5 United States (US) Monoclonal Antibody Market Revenues & Volume Share, By Source, 2021 & 2031F

3.6 United States (US) Monoclonal Antibody Market Revenues & Volume Share, By Production, 2021 & 2031F

3.7 United States (US) Monoclonal Antibody Market Revenues & Volume Share, By Indication, 2021 & 2031F

3.8 United States (US) Monoclonal Antibody Market Revenues & Volume Share, By End use, 2021 & 2031F

4 United States (US) Monoclonal Antibody Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases requiring monoclonal antibody treatments

4.2.2 Technological advancements in monoclonal antibody research and development

4.2.3 Rising demand for targeted therapies with fewer side effects

4.3 Market Restraints

4.3.1 High cost associated with monoclonal antibody therapies

4.3.2 Stringent regulatory requirements for approval and commercialization

4.3.3 Competition from biosimilars impacting pricing and market share

5 United States (US) Monoclonal Antibody Market Trends

6 United States (US) Monoclonal Antibody Market, By Types

6.1 United States (US) Monoclonal Antibody Market, By Source

6.1.1 Overview and Analysis

6.1.2 United States (US) Monoclonal Antibody Market Revenues & Volume, By Source, 2021- 2031F

6.1.3 United States (US) Monoclonal Antibody Market Revenues & Volume, By Murine, 2021- 2031F

6.1.4 United States (US) Monoclonal Antibody Market Revenues & Volume, By Chimeric, 2021- 2031F

6.1.5 United States (US) Monoclonal Antibody Market Revenues & Volume, By Humanized, 2021- 2031F

6.1.6 United States (US) Monoclonal Antibody Market Revenues & Volume, By Human, 2021- 2031F

6.2 United States (US) Monoclonal Antibody Market, By Production

6.2.1 Overview and Analysis

6.2.2 United States (US) Monoclonal Antibody Market Revenues & Volume, By In Vivo, 2021- 2031F

6.2.3 United States (US) Monoclonal Antibody Market Revenues & Volume, By In Vitro, 2021- 2031F

6.3 United States (US) Monoclonal Antibody Market, By Indication

6.3.1 Overview and Analysis

6.3.2 United States (US) Monoclonal Antibody Market Revenues & Volume, By Cancer, 2021- 2031F

6.3.3 United States (US) Monoclonal Antibody Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F

6.3.4 United States (US) Monoclonal Antibody Market Revenues & Volume, By Inflammatory Diseases, 2021- 2031F

6.3.5 United States (US) Monoclonal Antibody Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.3.6 United States (US) Monoclonal Antibody Market Revenues & Volume, By Microbial Diseases, 2021- 2031F

6.3.7 United States (US) Monoclonal Antibody Market Revenues & Volume, By Others, 2021- 2031F

6.4 United States (US) Monoclonal Antibody Market, By End use

6.4.1 Overview and Analysis

6.4.2 United States (US) Monoclonal Antibody Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 United States (US) Monoclonal Antibody Market Revenues & Volume, By Research Institutes, 2021- 2031F

6.4.4 United States (US) Monoclonal Antibody Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Monoclonal Antibody Market Import-Export Trade Statistics

7.1 United States (US) Monoclonal Antibody Market Export to Major Countries

7.2 United States (US) Monoclonal Antibody Market Imports from Major Countries

8 United States (US) Monoclonal Antibody Market Key Performance Indicators

8.1 Number of FDA approvals for new monoclonal antibody therapies

8.2 Research and development investment in monoclonal antibody technologies

8.3 Patient adherence and persistence rates for monoclonal antibody treatments

9 United States (US) Monoclonal Antibody Market - Opportunity Assessment

9.1 United States (US) Monoclonal Antibody Market Opportunity Assessment, By Source, 2021 & 2031F

9.2 United States (US) Monoclonal Antibody Market Opportunity Assessment, By Production, 2021 & 2031F

9.3 United States (US) Monoclonal Antibody Market Opportunity Assessment, By Indication, 2021 & 2031F

9.4 United States (US) Monoclonal Antibody Market Opportunity Assessment, By End use, 2021 & 2031F

10 United States (US) Monoclonal Antibody Market - Competitive Landscape

10.1 United States (US) Monoclonal Antibody Market Revenue Share, By Companies, 2024

10.2 United States (US) Monoclonal Antibody Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Monoclonal Antibody Market

Eritrea Monoclonal Antibody Market

Estonia Monoclonal Antibody Market

Ethiopia Monoclonal Antibody Market

Fiji Monoclonal Antibody Market

Finland Monoclonal Antibody Market

Global Monoclonal Antibody Market

Middle East Monoclonal Antibody Market

North America Monoclonal Antibody Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here